Analyst Profile

Followed by 130 followers
.
Geoff Porges

Geoff Porges

SVB Securities
Wall Street Analyst
#3,366 out of 8,160 Wall Street Analysts
#7,929 out of 24,427 experts

Success Rate

47%
114 out of 243 transactions made a profit

Average Return

+1.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Geoff Porges's trades since 2013 and holding each position for 1 Year would result in 46.91% of your transactions generating a profit, with an average return of 1.4% per rating.

Stock Rating Distribution

555Ratings
59.46% Buy
39.46% Hold
1.08% Sell
Distribution of Geoff Porges's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market
United KingdomUK Market

Best Rating

Stock:
Pandion Therapeutics, Inc.
(PAND)
Rating:Buy
Date:Aug 11, 2020 - Feb 25, 2021
Return:+217.20%
The most profitable rating made by Geoff Porges

Geoff Porges's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
ONXX
Onyx Pharma
Jul 01, 2013
Hold
Reiterated
1Ratings
0.00%
DNDNQ
Dendreon Corp
Mar 04, 2014
Hold
Downgraded
3Ratings
50%
+3.25%
~CEG
DEL_Constellation Energy Group
Jul 06, 2016
Hold
Reiterated
1Ratings
0.00%
Eli Lilly & Co
Jul 27, 2016
Buy
Reiterated
$105.00
(-71.98% Downside)
1Ratings
100%
+2.10%
MDVN
Medivation
Aug 10, 2016
Hold
Reiterated
13Ratings
50%
+28.65%
Johnson & Johnson
Sep 08, 2016
Buy
Reiterated
$140.00
(-21.74% Downside)
2Ratings
100%
+11.65%
Intra-Cellular Therapies
Apr 03, 2018
Buy
Reiterated
$25.00
(-53.77% Downside)
1Ratings
0%
-35.10%
ADMS
Adamas Pharmaceuticals
Apr 04, 2018
Buy
Initiated
1Ratings
0%
-72.90%
Adicet Bio
Jul 26, 2018
Buy
Reiterated
2Ratings
0%
-42.55%
EPZM
Epizyme
Sep 25, 2018
Hold
Initiated
$11.00
(648.30% Upside)
6Ratings
25%
-23.10%
List of latest recommendations made by Geoff Porges. Click to expand and see Geoff Porges's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >